XGN News and Press, Exagen Inc.

2026-03-08 09:30:25 ET More on Avino Silver & Gold Mines Ltd., Harmony Gold Mining, etc. Zumtobel Group AG (ZMTBY) Q3 2026 Earnings Call Transcript Zumtobel Group AG 2026 Q3 - Results - Earnings Call Presentation Buy Oracle's 'Bubble Fears' Before Next Week's Q3 ...

CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, 2025, before the market opens on Tuesday, March 10, 2026. John Aballi, President and Chief Executiv...

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, in line with prior financial guidance. Select Prelimi...

CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences: 16 th Annual Craig-Hallum Alpha Select Conference Date:...

2025-11-04 15:57:15 ET More on Exagen Exagen Inc. (XGN) Q3 2025 Earnings Call Transcript Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now Exagen GAAP EPS of -$0.31 misses by $0.15, revenue of $17.24M beats by $0.34M Seeking Alpha’s...

2025-11-04 15:56:26 ET Exagen Inc. (XGN) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ryan Douglas - Investors Relations Officer John Aballi - CEO, President & Director Jeffrey Black - CFO & Corporate Secretary ... Read ...

2025-11-04 08:09:31 ET More on Exagen Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now Seeking Alpha’s Quant Rating on Exagen Historical earnings data for Exagen Financial information for Exagen Read the full article on S...

CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates. Q3 2025 Highlights and Recent Corporate Updates: ...

Advanced Energy Industries Inc. (AEIS) is expected to report $1.16 for Q3 2025 Neuropace Inc. (NPCE) is expected to report $-0.2 for Q3 2025 Oportun Financial Corporation (OPRT) is expected to report $0.2 for Q3 2025 trivago N.V. (TRVG) is expected to report $0.07 for Q3 2025 Alle...

CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2025, being held October 24-29, 2025...